Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A M Fischer

Showing results (1-10 of 110) with videos related to

Pageof 11
Sort By:
La Revue Du Praticien|September 15, 1991
[Hirudin. A new and promising anticoagulant from leech]M Aiach, A M Fischer
Revue Des Maladies Respiratoires|October 16, 2019
[What are the special features of treatment in the anti-phospho-lipid syndrome?]Y Benhamou, A Delluc, A-M Fischer, et al.
Advances in Experimental Medicine and Biology|January 1, 1983
Diffusion of carbon dioxide in blood protein solutionsP Stroeve, J Spavins, A M Fischer, et al.
Revue Des Maladies Respiratoires|November 9, 2019
[What are the options for the initial anticoagulant treatment of a PE and a proximal DVT?]F Couturaud, A-M Fischer, S Laporte, et al.
Comptes Rendus Des Seances De L'Academie Des Sciences. Serie D, Sciences Naturelles|March 12, 1979
[Heparin inhibition of the antithrombin activity of alpha-2-macroglobulin]A M Fischer, A Bros, S Rafowicz, et al.
British Journal of Haematology|June 1, 1997
Prevalence of the FVQ506 (factor V Leiden) mutation in the normal and thrombophilic Algerian populationO Chafa, A Reghis, A Aubert, et al.
La Revue De Medecine Interne|October 5, 2010
[Hydroxychloroquine: a new therapeutic approach to the thrombotic manifestations of antiphospholipid syndrome]J Szymezak, A Ankri, A-M Fischer, et al.
Thrombosis and Haemostasis|April 30, 1982
A comparison of pentosan polysulphate (SP54) and heparin. I: Mechanism of action on blood coagulationA M Fischer, T W Barrowcliffe, D P Thomas
Thrombosis Research|May 1, 1980
Heparin prevents thrombin inhibition by alpha 2 macroglobulinA M Fischer, A Bros, S Rafowicz, et al.
Thrombosis Research|April 15, 2004
Low molecular weight fucoidan promotes FGF-2-induced vascular tube formation by human endothelial cells, with decreased PAI-1 release and ICAM-1 downregulationD Chabut, A M Fischer, D Helley, et al.
Pageof 11

Showing results (1-10 of 110) with videos related to

Sort By:
Pageof 11
La Revue Du Praticien|September 15, 1991
[Hirudin. A new and promising anticoagulant from leech]M Aiach, A M Fischer
Revue Des Maladies Respiratoires|October 16, 2019
[What are the special features of treatment in the anti-phospho-lipid syndrome?]Y Benhamou, A Delluc, A-M Fischer, et al.
Advances in Experimental Medicine and Biology|January 1, 1983
Diffusion of carbon dioxide in blood protein solutionsP Stroeve, J Spavins, A M Fischer, et al.
Revue Des Maladies Respiratoires|November 9, 2019
[What are the options for the initial anticoagulant treatment of a PE and a proximal DVT?]F Couturaud, A-M Fischer, S Laporte, et al.
Comptes Rendus Des Seances De L'Academie Des Sciences. Serie D, Sciences Naturelles|March 12, 1979
[Heparin inhibition of the antithrombin activity of alpha-2-macroglobulin]A M Fischer, A Bros, S Rafowicz, et al.
British Journal of Haematology|June 1, 1997
Prevalence of the FVQ506 (factor V Leiden) mutation in the normal and thrombophilic Algerian populationO Chafa, A Reghis, A Aubert, et al.
La Revue De Medecine Interne|October 5, 2010
[Hydroxychloroquine: a new therapeutic approach to the thrombotic manifestations of antiphospholipid syndrome]J Szymezak, A Ankri, A-M Fischer, et al.
Thrombosis and Haemostasis|April 30, 1982
A comparison of pentosan polysulphate (SP54) and heparin. I: Mechanism of action on blood coagulationA M Fischer, T W Barrowcliffe, D P Thomas
Thrombosis Research|May 1, 1980
Heparin prevents thrombin inhibition by alpha 2 macroglobulinA M Fischer, A Bros, S Rafowicz, et al.
Thrombosis Research|April 15, 2004
Low molecular weight fucoidan promotes FGF-2-induced vascular tube formation by human endothelial cells, with decreased PAI-1 release and ICAM-1 downregulationD Chabut, A M Fischer, D Helley, et al.
Pageof 11